Education
About Us
Working with TipRanks
Follow Us
Vincerx Pharma Inc (VINC)
NASDAQ:VINC
Total Valuation
Vincerx Pharma Inc has a market cap or net worth of $1.44M. The enterprise value is $6.71M.
Market Cap$1.44M
Enterprise Value$6.71M
Share Statistics
Vincerx Pharma Inc has 5,234,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,234,000
Owned by Insiders75.01%
Owned by Institutions0.03%
Financial Efficiency
Vincerx Pharma Inc’s return on equity (ROE) is -11.04 and return on invested capital (ROIC) is -1155.03%.
Return on Equity (ROE)-11.04
Return on Assets (ROA)-3.76
Return on Invested Capital (ROIC)-1155.03%
Return on Capital Employed (ROCE)-11.55
Revenue Per Employee0.00
Profits Per Employee-2.51M
Employee Count12
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Vincerx Pharma Inc is -0.33. Vincerx Pharma Inc’s PEG ratio is >-0.01.
PE Ratio-0.33
PS Ratio2.42
PB Ratio3.67
Price to Fair Value3.67
Price to FCF-0.38
Price to Operating Cash Flow-0.38
PEG Ratio>-0.01
Income Statement
In the last 12 months, Vincerx Pharma Inc had revenue of 0.00 and earned -30.07M in profits. Earnings per share was -15.85.
Revenue0.00
Gross Profit0.00
Operating Income-31.46M
Pretax Income-30.07M
Net Income-30.07M
EBITDA-31.46M
Earnings Per Share (EPS)-15.85
Cash Flow
In the last 12 months, operating cash flow was -27.96M and capital expenditures 0.00, giving a free cash flow of -27.96M billion.
Operating Cash Flow-27.96M
Free Cash Flow-27.96M
Free Cash Flow per Share-5.34
Dividends & Yields
Vincerx Pharma Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.02
52-Week Price Change-98.39%
50-Day Moving Average0.81
200-Day Moving Average6.94
Relative Strength Index (RSI)24.31
Average Volume (3m)1.35M
Important Dates
Vincerx Pharma Inc upcoming earnings date is May 8, 2025, TBA Not Confirmed.
Last Earnings DateApr 1, 2025
Next Earnings DateMay 8, 2025
Ex-Dividend Date―
Financial Position
Vincerx Pharma Inc as a current ratio of 1.21, with Debt / Equity ratio of 18.00%
Current Ratio1.21
Quick Ratio1.21
Debt to Market Cap0.00
Net Debt to EBITDA0.16
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Vincerx Pharma Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Vincerx Pharma Inc EV to EBITDA ratio is -0.16, with an EV/FCF ratio of -0.19.
EV to Sales0.00
EV to EBITDA-0.16
EV to Free Cash Flow-0.19
EV to Operating Cash Flow-0.19
Balance Sheet
Vincerx Pharma Inc has $10.09M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$8.45M billion.
Cash & Marketable Securities$10.09M
Total Debt$0.00
Net Cash-$8.45M
Net Cash Per Share-$1.61
Tangible Book Value Per Share$1.44
Margins
Gross margin is 39.73%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin39.73%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Vincerx Pharma Inc is $2.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$2.00
Price Target Upside614.29% Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast48.17%